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Abstract
 
Examining the rate of in vivo T cell turnover (proliferation) in aged mice revealed a marked
reduction in turnover at the level of memory-phenotype CD44
 
hi
 
 CD8
 
 
 
 cells relative to young
mice. Based on adoptive transfer experiments, the reduced turnover of aged CD44
 
hi
 
 CD8
 
 
 
cells reflected an inhibitory influence of the aged host environment. Aged CD44
 
hi
 
 CD8
 
 
 
 cells
also showed poor in vivo responses to IL-15 and IL-15–inducing agents, but responded well to
IL-15 in vitro. Two mechanisms could account for the reduced turnover of aged CD44
 
hi
 
CD8
 
 
 
 cells in vivo. First, aging was associated with a prominent and selective increase in Bcl-2
expression in CD44
 
hi
 
 CD8
 
 
 
 cells. Hence, the reduced turnover of aged CD44
 
hi
 
 CD8
 
 
 
 cells
may in part reflect the antiproliferative effect of enhanced Bcl-2 expression. Second, the im-
paired in vivo response of aged CD44
 
hi
 
 CD8
 
 
 
 cells to IL-15 correlated with increased serum
levels of type I interferons (IFN-I) and was largely reversed by injection of anti–IFN-I anti-
body. Hence the selective reduction in the turnover of aged CD44
 
hi
 
 CD8
 
 
 
 cells in vivo may
reflect the combined inhibitory effects of enhanced Bcl-2 expression and high IFN-I levels.
Key words: aging • CD8
 
 
 
 cells • IFN-I • IL-15 • T cell turnover
 
Introduction
 
It is well-established that aging is associated with immuno-
logical defects, especially at the level of T cells (1–4). The
mechanisms governing hyporesponsiveness in aged T cells
are poorly understood. A priori, there could be defects at
the level of T cells per se or in APCs or both.
With regard to APCs, there are several reports that mac-
rophages/monocytes from old donors can be inhibitory for
T proliferative responses (4–6). Such inhibition could in-
volve multiple mechanisms, including increased production
of PGE
 
2 
 
(7, 8) and TGF-
 
 
 
 (9). Nevertheless, defects in
APC function are not an invariable finding in old age (10–
12). Moreover, defects in T cell function are apparent in
APC-free systems (2) and in situations where defined cell
lines are used as APCs (3).
For T cells, studies with purified populations of APC-
depleted murine T cell subsets have demonstrated that old T
cells display a number of early activation defects after CD3
ligation in vitro (for a review, see reference 2). To a large
extent, these changes in signal transduction are attributable
to the marked increased frequency of memory-phenotype
cells in old T cell populations (3, 13–16). Nevertheless, at
least some of the signal transduction defects found in old T
cells are apparent at the level of purified naive phenotype
CD4
 
 
 
 cells (2). The defects in these cells include decreased
proliferative responses and IL-2 production and correlate
with increased expression of P-glycoprotein (2, 15). These
data refer to CD4
 
 
 
 cells. Whether aging is associated with
defects at the level of CD8
 
 
 
 cells is less clear.
In considering the defective function of old T cells, the
lifespan of these cells is an important issue. Since de novo
production of T cells by the thymus declines rapidly in old
age (17), most of the T cells found in old age are probably
the long-term progeny of T cells generated in young life.
Indeed, parking studies in mice suggest that, at a population
level, T cells in this species have an almost indefinite
lifespan (
 
 
 
2 y) (18). Since total T cell numbers remain rel-
atively constant from puberty to old age, T cells are pre-
sumably subject to homeostatic mechanisms which balance
the rate of cell death and proliferation (19–21). In this re-
spect there is a paucity of firm information on the normal
in vivo physiology of T cells in aged hosts, especially with
regard to T cell turnover and lifespan. Previous work from
this laboratory on T cell turnover in normal young mice
showed that, although both naive- and memory-phenotype
cells are long lived at a population level, the background
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rate of proliferation (turnover) of these cells is much faster
for memory- than for naive-phenotype cells (22).
For memory-phenotype (CD44
 
hi
 
) CD8
 
 
 
 cells there is
increasing evidence that the survival and turnover of these
cells is under the control of IL-15 (23–28). In particular,
numbers of CD44
 
hi
 
 CD8
 
 
 
 cells are selectively reduced in
IL-15
 
–/–
 
 mice (26) and the normal turnover of CD44
 
hi
 
CD8
 
 
 
 cells in vivo can be partly blocked by antibodies to
IL-2R
 
 
 
 (CD122), an important component of the receptor
for IL-15 (and IL-2; reference 27). In this paper, we show
that aging is associated with a selective reduction in the
turnover of CD44
 
hi
 
 CD8
 
 
 
 cells and an impaired response
of these cells to IL-15 in vivo (though not in vitro). The
reduced turnover of CD44
 
hi
 
 CD8
 
 
 
 cells in vivo was not
seen after transfer to young mice. Evidence is presented
that the slow turnover of CD44
 
hi
 
 CD8
 
 
 
 cells in aged mice
may reflect the combined inhibitory effects of Bcl-2 over-
expression and increased levels of type I IFN-I.
 
Materials and Methods
 
Mice.
 
C57BL/6 (B6) mice together with IL-2R
 
 
 
–/–
 
 (29) and
Bcl-2 transgenic (30) mice, both on a B6 background, were ob-
tained from The Jackson Laboratory; IL-2R
 
 
 
–/–
 
 mice were de-
rived from heterozygous IL-2R
 
 
 
 
 
/–
 
 mice purchased from The
Jackson Laboratory. Mice were aged by maintaining young mice
in our animal facility for 2 y or more under specific pathogen-
free conditions; routine serological testing of mice for a variety of
pathogens were negative. For studies on long-term T cell turn-
over in vivo, adult thymectomized (ATx)
 
* 
 
mice (22) were used.
For aged mice, ATx was performed at 1 y and the mice were
used 1 y later; sham thymectomized (STx) mice were used as
controls. For young mice, mice were subjected to ATx or STx at
4–6 wk and used 3–4 wk later.
 
Flow Cytometry.
 
As described elsewhere (22, 23), surface
markers on T cell subsets were defined by staining spleen and/or
LN cells with Cy5-coupled anti-CD4 and anti-CD8 mAbs fol-
lowed by biotin- or phycoerythrin-coupled mAbs specific for
CD44, B7.1, B7.2 CD69, CD25, CD122, CD44, Ly6C, and in-
tracellular adhesion molecule 1; these mAbs were purchased from
BD PharMingen. Biotinylated mAbs were detected with Red-
670 streptavidin (GIBCO BRL). T cells were stained internally
for Bcl-2 and Bcl–X
 
L
 
 as described previously (31). In brief, cells
were stained for surface markers, then fixed with paraformalde-
hyde, treated with saponin and then stained with a hamster anti–
mouse Bcl-2 mAb (BD PharMingen; 3F11) or with a polyclonal
rabbit antiserum specific for Bcl–X
 
L
 
 (provided by John Reed,
Burnham Institute, La Jolla, CA) followed by FITC-conjugated
anti–rabbit antibody. Stained cells were analyzed on a FACSort™
flow cytometer.
 
T Cell Turnover In Vivo.
 
As described previously (22), T cell
proliferation in vivo was measured by maintaining mice continu-
ously on bromodeoxyuridine (BrdU) (Sigma-Aldrich) dissolved in
the drinking water. To detect BrdU incorporation, spleen and LN
cells were surface stained for CD4 or CD8 and CD44 or IL-2R
 
 
 
,
fixed and then stained internally with an anti-BrdU mAb. For
measuring BrdU incorporation on adoptive transfer, the donor
and hosts differed with respect to Ly5.1 versus Ly5.2 or Thy 1.1
versus Thy 1.2. Donor and host cells were then defined by stain-
ing cells with allele-specific anti-Ly5 and anti-Thy 1 mAbs (32).
In some studies, T cell turnover on adoptive transfer was mea-
sured by labeling T cells in vitro before injection with the intra-
cellular fluorescent dye CFSE (32). As measured by flow cytome-
try, each division of CFSE-labeled cells causes a twofold reduction
in mean fluorescence intensity (MFI) in the daughter cells, with
the result that extensive cell proliferation results in a progressive
step-wise reduction in MFI. For examining T proliferative re-
sponses to IL-15 and Poly I:C in vivo, graded concentrations of
mouse rIL-15 (e-Bioscience) were injected intravenously and Poly
I:C (100 
 
 
 
g/mouse) was injected intraperitoneally; in some mice,
polyvalent neutralizing antiserum specific for IFN-
 
 
 
 (Access Bio-
medical) was injected intravenously at 36 and 48 h. Mice were
placed on BrdU water, preceded by an intraperitoneal injection of
BrdU on day 0. BrdU incorporation was measured in spleen and
LNs on day 2 for IL-15 and day 3 for Poly I:C.
 
T Cell Proliferation In Vitro.
 
Purified subsets of CD44
 
hi
 
 CD8
 
 
 
cells were prepared from LNs by FACS
 
®
 
 sorting and cultured at
0.5 
 
 
 
 10
 
6
 
 cells per milliliter with graded concentrations of rIL-15 
 
 
 
IFN-
 
 
 
 (Access Biomedical). 
 
3
 
[H]TdR (1 
 
 
 
Ci/ml) was added
during the last 8 h of culture. 
 
3
 
[H]TdR incorporation was mea-
sured on days 2–4.
 
Apoptosis.
 
To measure spontaneous apoptosis, nylon-wool-
purified LN T cells were cultured at 10
 
6
 
 cells per milliliter in 1 ml
24-well plates for 1 or 2 d in standard RPMI 1640 tissue culture
medium supplemented with 10% FCS, glutamine, antibiotics,
and 2-ME (33). Apoptosis was measured by TUNEL staining
(33) after surface staining for CD4 or CD8 and CD44.
 
Effect of Cytokines on Bcl-2 Expression.
 
FACS
 
®
 
-sorted CD44
 
hi
 
CD8
 
 
 
 cells were cultured at 10
 
6
 
 cells per milliliter with various cy-
tokines (purchased from R&D Systems) in standard tissue culture
medium for 18 h and then stained internally for Bcl-2 expression.
 
Cytokine Concentrations.
 
Levels of cytokines in serum and cell
supernatants were measured by ELISA. In brief, serum or culture
supernatants, together with known concentrations of recombi-
nant TNF-
 
 
 
, IFN-
 
 
 
, IL-12, and IFN-
 
 
 
 as controls, were diluted
serially in saline and added to plastic plates coated with antibodies
specific for IFN-
 
  
 
 (polyclonal rabbit antibody purchased from
Access Biomedical, San Diego, CA), IFN-
 
 
 
, TNF-
 
 
 
, or IL-12
(BD PharMingen). After incubation at 37
 
 
 
C for 2 h, the plates
were washed, supplemented with biotinylated antibodies, washed
again, followed by addition of streptavidin-peroxidase. After 1 h,
the substrate 
 
O
 
-phenyldiamine was added. The plates were ana-
lyzed with an ELISA reader after stopping the reaction with 25%
H
 
2
 
SO
 
4
 
. Cytokine induction by Poly I:C (Sigma-Aldrich) was
elicited in vivo by injecting mice intraperitoneally with 100 
 
 
 
g
Poly I:C and in tissue culture by adding graded concentrations of
Poly I:C to thioglycollate-induced macrophages in vitro.
 
RT-PCR.
 
Total RNA was isolated from whole spleen. First
strand cDNA synthesis was performed using a Superscript Pream-
plification System (GIBCO BRL). PCR reactions were primed
either with pairs of oligonucleotide primers corresponding to the
3
 
 
 
 region of mouse IL-15 (23) or IFN-
 
 
 
 (Stratagene) or to the
housekeeping gene G3PDH (23). PCR were performed for 30
cycles, with each cycle being 1 min at 94
 
 
 
C, 2 min at 54
 
 
 
C, and 3
min at 72
 
 
 
C. PCR samples were resolved on 1.5% agarose gels.
 
Results
 
T Cells Were Characterized in Young versus Aged C57BL/6
(B6) Mice.
 
For aged mice, young B6 mice were pur-
chased and then maintained in our animal colony for up to
 
*
 
Abbreviations used in this paper:
 
 ATx, adult thymectomized; BrdU, bromode-
oxyuridine; MFI, mean fluorescence intensity; STx, sham thymectomized. 
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2 y. To prevent de novo production of T cells, ATx mice
were used in some experiments. For old mice, the thymus
was removed at 1 y and the mice were then tested 1 y later;
as controls STx mice were used. In general, there was little
difference in the results obtained for ATx, STx, and normal
(unoperated) old mice. Unless stated otherwise, the age of
the mice used in the experiments discussed below was 
 
 
 
2 y
(22–26 mo) for aged mice and 2–3 mo for young mice.
Mice with tumors or lymphadenopathy were discarded.
 
T Cell Turnover.
 
To examine T cell turnover, young
versus old B6 mice were given BrdU continuously in the
drinking water. Groups of the mice were killed at intervals
and suspensions of spleen and LN cells were stained for sur-
face markers followed by fixation and intracellular staining
for BrdU using an anti-BrdU mAb. Naive- and memory-
phenotype T cells were subsetted on the basis of CD44 and
IL-2R
 
 
 
 (CD122) expression (illustrated for BrdU-labeled
aged T cells in the right of Fig. 1). For IL-2R
 
 
 
, it should
Figure 1. Turnover of T cell subsets in old and
young mice. In A and B, groups of ATx old (2 y)
and ATx young (3 mo) mice were placed on BrdU
water for various periods. Spleen and LN suspen-
sions were surface stained for CD4 and CD8 expres-
sion and also for expression of CD44 and IL-2R .
After fixation, the cells were then stained internally
for BrdU incorporation using an anti-BrdU mAb
and FACS® analyzed. The data show the mean per-
centage of BrdU labeling of pooled LN cells from
two mice per group; labeling in spleen was quite
similar. The bar graphs on the left show the per-
centage of T cells that display a memory phenotype
in young versus old mice; dot plots for defining
CD44hi versus CD44lo and IL-2R hi versus IL-2R int
(for CD8  cells) and IL-2R int versus IL-2R lo (for
CD4  cells) on aged ATx CD8  cells from a repre-
sentative mouse given BrdU for 26 d are shown on
the right; quadrants were set on the basis of parallel
staining of young T cells (data not shown). Note
that for total (unseparated) CD8  cells, the lack of a
difference in turnover between young and old cells
reflected the dominance of naive T cells (slow turn-
over) in young mice. In C, data on CD8  cells
from ATx mice (the same as in A) are compared
with data from STx (euthymic) mice. The data show
mean values (  SD) for two mice per point; for sev-
eral of the points, SDs were too small to display. 
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be noted that expression of IL-2R
 
 
 
 is much higher on
CD8
 
 
 
 than CD4
 
 
 
 cells (23). Hence, naive- and memory-
phenotype cells were defined as being IL-2R
 
 
 
int
 
 and IL-
2R
 
 
 
hi
 
, respectively, for CD8
 
 
 
 cells and IL-2R
 
 
 
lo
 
 and IL-
2R
 
 
 
int
 
 for CD4
 
 
 
 cells.
In agreement with previous reports (1–3), the propor-
tion of memory-phenotype CD8
 
 
 
 (CD44
 
hi
 
 IL-2R
 
 
 
hi
 
) and
CD4
 
 
 
 (CD44
 
hi
 
 IL-2R
 
 
 
int
 
) cells was far higher in old mice
than in young mice (Fig. 1). Data for BrdU incorporation
by LN T cell subsets for ATx mice are shown in Fig. 1 A
and B; data for spleen T cells were very similar. The data
make several points.
For total unseparated CD8
 
 
 
 and CD4
 
 
 
 cells, the turn-
over (BrdU incorporation) of CD8
 
 
 
 cells in young and old
mice was very similar (see Fig. 1 legend for explanation),
whereas the turnover of CD4
 
 
 
 cells was faster in old mice
than young mice.
Confirming previous findings (22), the turnover of T
cell subsets in young mice was slow for naive-phenotype
cells and rapid for memory-phenotype cells, both for
CD8
 
 
 
 and CD4
 
 
 
 cells. The turnover of T cell subsets in
old mice was distinctly different in three respects. First, in
marked contrast to young mice, the difference in the turn-
over of naive- and memory-phenotype cells in old mice
was mild or nonexistent. Second, for CD4
 
 
 
 cells (but not
CD8
 
 
 
 cells) naive-phenotype cells paradoxically had a
faster turnover in old mice than in young mice; a likely ex-
planation for this finding is that, for CD4
 
 
 
 cells, many of
the naive-phenotype cells in old mice are not truly naive
but represent revertants from memory-phenotype cells
(22). Third, and most importantly, the turnover of mem-
ory-phenotype CD8
 
 
 
 cells was much slower in old than
young mice. Slow turnover of memory-phenotype cells in
old mice also applied to CD4
 
 
 
 cells but was less prominent
than for CD8
 
 
 
 cells.
The data in Fig. 1 A and B are representative of three
different experiments on ATx mice. Data on euthymic
(STx) mice were comparable and are illustrated in Fig. 1 C
for CD8
 
 
 
 cells. For the experiments discussed hereafter,
nonoperated mice were used.
 
T Cell Turnover on Adoptive Transfer to Young versus Old
Hosts.
 
The key finding in the above experiments is that
the turnover of memory-phenotype CD8
 
 
 
 cells was much
slower in old mice than in young mice. A priori, this find-
ing could reflect an intrinsic defect in old T cells per se or
in the nonT microenvironment of old mice. To distinguish
between these two possibilities, we examined whether the
reduced turnover of old memory-phenotype CD8
 
 
 
 cells
could be overcome by adoptively transferring old T cells to
young hosts.
In the experiment shown in Fig. 2 A, purified LN T
cells from old mice were transferred to Thy-1 different
young hosts; 3 d later the T cell recipients plus control old
and young mice were placed on BrdU water for 3 d. The
notable finding was that BrdU incorporation by old
CD44
 
hi
 
 CD8
 
 
 
 cells transferred to young hosts was almost
as high as for the population of young host CD44
 
hi
 
 CD8
 
 
 
cells (Fig. 2 A, top). These findings thus indicated that the
slow turnover of CD44
 
hi
 
 CD8
 
 
 
 cells in intact old mice
could be substantially reversed by transferring the cells to
young hosts. Similar findings applied when a mixture of
Thy 1–marked old and young T cells were CFSE labeled
(32) and transferred to young hosts. In this situation, prolif-
eration of donor-derived old CD44
 
hi
 
 CD8
 
 
 
 cells was al-
most as high as for donor-derived young CD44
 
hi
 
 CD8
 
 
 
(Fig. 2 A,
 
 
 
bottom).
These findings implied that the reduced turnover of old
T cells in old mice did not reflect an intrinsic defect in T
cells but in the host environment. If so, it would follow
that young T cells would show a reduction in turnover af-
ter transfer to old hosts. This was indeed the case. Thus, af-
ter transfer of CFSE-labeled young T cells to young versus
old hosts, proliferation was extensive in young hosts but
quite limited in old hosts (Fig. 2 B).
A corollary of the above data is that if a mixture of old
and young T cells was transferred to young versus old
hosts, the young and old T cells would both proliferate
well in young hosts but poorly in old hosts. Experiments
with allotype-marked CFSE-labeled cells verified this pre-
diction (Fig. 2 C). It should be noted that in Fig. 2 B and C
(but not 2 A) the host mice were pretreated with light irra-
diation to facilitate detection of the donor T cells. Host ir-
radiation enhances “homeostatic” proliferation of donor T
cells (32) but the results in irradiated and nonirradiated
mice were qualitatively similar (compare Fig. 2 A, bottom,
with Fig. 2 C, top).
Collectively, the above data indicate that, both in normal
and irradiated hosts, the impaired turnover of memory-
phenotype CD8
 
 
 
 cells in old mice reflects the particular
milieu of the host environment. It should be mentioned
that higher turnover of old CD8
 
 
 
 cells in young hosts than
in old hosts has recently been reported by Ku et al. (34).
Our finding that this difference applies to both irradiated
and nonirradiated hosts argues against the suggestion of Ku
et al. that reduced turnover in old hosts reflects increased
competition for cytokines because of the increase in mem-
ory-phenotype T cells.
 
Surface Markers.
 
To examine whether the reduced
turnover of old CD44
 
hi
 
 CD8
 
 
 
 cells correlated with surface
marker changes, old versus young T cells were stained for
expression of various cell-surface molecules. Gating on
CD44
 
hi
 
 CD8
 
 
 
 cells showed no obvious difference in the
expression of CD62L, CD45RB, CD69, CD25, B7.1,
B7.2, Ly6C, and IL-2R
 
 
 
 on old versus young T cells (data
not shown). In particular, CD44
 
hi
 
 CD8
 
 
 
 cells in old mice
closely resembled young T cells in expressing a high den-
sity of IL-2R
 
 
 
; as discussed earlier, IL-2R
 
 
 
 is an important
component of the receptor for IL-15 (and IL-2). The only
noticeable difference for this marker was that, for CD8
 
 
 
cells, the proportion of CD44
 
hi
 
 CD8
 
 
 
 cells that were IL-
2R
 
 
 
hi
 
 was higher in old mice (90–95%) than in young
mice (60–70%) (data not shown).
 
Bcl-2 and Bcl–X
 
L
 
.
 
Since overexpression of Bcl-2 or
Bcl–X
 
L
 
 is reported to inhibit T cell proliferation (30, 35, 
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36), the reduced turnover of memory-phenotype CD8
 
 
 
cells in old mice could be a reflection of enhanced expres-
sion of Bcl-2 and/or Bcl–X
 
L
 
. In young mice, it was shown
previously that Bcl-2 expression is higher in CD44
 
hi
 
 CD8
 
 
 
cells than in CD44
 
lo
 
 CD8
 
 
 
 cells but equivalent in CD44
 
hi
 
and CD44
 
lo
 
 CD4
 
 
 
 cells (37); Bcl–X
 
L
 
 expression was not
examined. Intracellular staining for Bcl–2 and Bcl–X
 
L
 
 ex-
pression in young (2 mo) versus old (14 and 27 mo) T cells
is shown in Fig. 3 A.
In young mice, confirming the above report, Bcl-2 ex-
pression was clearly higher in CD44
 
hi
 
 CD8
 
 
 
 cells than
CD44
 
lo
 
 CD8
 
 
 
 cells but was not elevated in CD44
 
hi
 
 CD4
 
 
 
cells relative to CD44
 
lo
 
 CD4
 
 
 
 cells. For Bcl–X
 
L
 
 expression,
the results were different. As for Bcl-2, Bcl–XL expression
in young T cells was appreciably higher in CD44hi cells than
CD44lo cells. In contrast to Bcl-2, however, upregulation of
Bcl–XL in CD44hi cells applied to both CD4  and CD8 
cells. Thus, Bcl-2 was selectively elevated in CD44hi CD8 
cells but not CD44hi CD4  cells whereas Bcl–XL was ele-
vated in both CD44hi CD4  cells and CD44hi CD8  cells.
In old mice, the notable finding was that elevation of
Bcl-2 expression was much more pronounced than in
young mice. Thus, Bcl-2 expression was 2–3-fold higher in
old CD44hi CD8  cells than in young CD44hi CD8  cells;
this finding applied both to direct MFI values for Bcl-2
staining and also to the ratio of Bcl-2:background staining
(shown numerically within each middle and lower panel of
Fig. 3 A). Bcl-2 expression also increased with age in
CD44lo CD8  cells, but this increase applied only to Bcl-2:
background staining ratios and not to direct MFI values for
Bcl-2 staining. In addition to Bcl-2 upregulation, old
CD44hi CD8  cells also showed a mild (30–50%) increase
in Bcl–XL expression relative to young cells.
These findings indicated that aging was associated with a
selective increase in the expression of Bcl-2, and to a lesser
extent Bcl–XL, in CD44hi CD8  cells. By contrast, aging
Figure 2. Turnover of o ld and
young T cells on adoptive transfer to
old versus young hosts. (A, top)
Doses of 107 nylon-wool-purified
LN T cells from old Thy 1.2 donors
were transferred intravenously into
young Thy 1.1 hosts. After 3 d, the
mice were placed on BrdU water for
3 d. Together with cells from nor-
mal old and young mice, LN cells
from young hosts given old T cells
were surface stained for CD8, Thy
1.2, Thy 1.1, and CD44 followed by
internal staining for BrdU. The data
(mean of three mice per group)
show the percentage of BrdU  cells
for gated CD44hi CD8  cells. In the
adoptive transfer system, donor and
host cells were detected on the basis
of Thy 1.1 versus Thy 1.2 expres-
sion. (A, bottom) Purified popula-
tions of old Thy 1.2 T cells and
young Thy 1.1 T cells were labeled
with CFSE and transferred intrave-
nously at a dose of 107 of each into
young Thy 1.1 hosts. LN cells were
removed from groups of these mice
at the intervals shown and stained for
CD8, CD44, Thy 1.1, and Thy 1.2.
Gating on young (Thy 1.1 ) versus
old (Thy 1.2 ) CD44hi CD8  cells,
the cells were analyzed for the inten-
sity of CFSE labeling. The data
show the percentage of CD44hi
CD8  cells that divided one or more times after transfer; the percentage of proliferation
was calculated from the percentage of cells in each CFSE peak, followed by correction for
cells that divided more than once. (B) Doses of 2   106 CFSE-labeled purified LN T cells
from young Thy 1.1 mice were transferred intravenously into young versus old hosts (Thy
1.2) pretreated with light irradiation (600 cGy). The data show CFSE labeling of donor (Thy 1.1 ) CD8  cells harvested from host LN on day 8. (C) A
mixed population of CFSE-labeled young and old T cells (106 of each) was transferred intravenously to 600 cGy young versus old hosts; different Ly 5
and Thy 1 markers were used to define the two populations of donor cells and distinguish these cells from the host cells. The data show CFSE labeling of
the donor cells recovered from host LN on day 8. (D) Doses of 2   107 LN T cells from young Bcl-2 transgenic mice (Ly5.1) were transferred intrave-
nously to young normal B6 Ly5.2 mice. At 1 mo after transfer the mice were given BrdU in the drinking water; lymphoid cells were then stained for sur-
face markers and BrdU incorporation. The data (mean of three mice per group) show the percentage of BrdU incorporation by CD44hi CD8  donor
versus host LN cells after 3 d or 10 d on BrdU. Similar findings were seen in a second experiment in which the time between cell transfer and BrdU ad-
ministration was reduced to 3 d (not shown). Note that for each experiment shown in A–D, the data are representative of 2–6 separate experiments.288 Aging and T Cell Turnover
caused little or no change in Bcl-2 or Bcl–XL expression in
CD44hi CD4  cells or in naive-phenotype cells.
The increased Bcl-2/Bcl–XL expression found in old
CD44hi CD8  cells might reflect altered exposure to cy-
tokines. To examine this possibility, purified CD44hi
CD8  cells from young mice were cultured overnight in
vitro with eight different cytokines and then stained for
Bcl-2 expression. Of the cytokines tested, only IL-15
caused a prominent (twofold) increase in Bcl-2 expression
(Fig. 3 B, left). Two other  c-controlled cytokines, IL-4
and IL-7, caused a mild increase in Bcl-2 expression,
whereas IFN-I (IFN- ), IFN- , and TNF-  had no effect
(see below). For IL-15, upregulation of Bcl-2 was restricted
to CD44hi CD8  cells and did not apply to CD44hi CD4 
cells (data not shown), which is consistent with the much
lower expression of IL-2R  on the latter cells (see above).
Significantly, unmanipulated CD44hi CD8  cells from IL-
2R –/– mice, i.e., cells that are unresponsive to IL-15 (and
IL-2), showed a prominent decrease in Bcl-2 expression
relative to normal cells (Fig. 3 B, right). It should be noted
that, unlike IL-15–/– mice, IL-2R –/– mice contain large
numbers of CD44hi CD8  cells, presumably reflecting un-
restrained MHC-driven IL-15–independent responses to
environmental antigens in the absence of inhibition by IL-2
(27, 29).
Apoptosis In Vitro. Since Bcl-2 and Bcl–XL are antiapop-
totic molecules (30, 35, 36), the elevation of these mole-
cules in old T cells would be expected to retard “back-
ground” death of these cells. To assess this possibility,
purified young versus old B6 T cells were cultured in stan-
dard tissue culture medium and then TUNEL stained to as-
sess apoptosis. The notable finding was that spontaneous
apoptosis in culture was far lower with old T cells than
with young T cells (Fig. 4). The resistance of old T cells to
spontaneous apoptosis was more prominent for CD8  cells
than CD4  cells and, especially on day 2 of culture, was
more pronounced for CD44hi cells than for CD44int/lo cells.
On day 2 of culture, relative to young T cells, apoptosis of
old T cell subsets was reduced by 3.7-fold for CD44hi
CD8  cells, 2.4-fold for CD44int/lo CD8  cells, 1.9-fold for
Figure 3. Bcl-2 and Bcl–XL expression in
young versus old T cells. (A) LN cells from
B6 mice aged 2, 14, and 27 mo were surface
stained for CD4, CD8 and CD44 and then,
after fixation and permeabilization, stained
internally for Bcl-2 or Bcl-XL. The data
show representative staining for Bcl-2 (top
panel) and mean MFI values (  SD) for
Bcl-2 and Bcl-XL staining (middle and
lower panels) for 3–6 mice per group; in the
middle and lower panels, ratios   SD of
MFI staining for Bcl-2 and Bcl–XL versus
MFI staining with an irrelevant control mAb
are inserted. (B) Effect of cytokines on Bcl-2
expression in young CD44hi CD8  cells.
(Left) CD44hi CD8  cells were purified by
FACS® sorting and cultured in 200 ng/ml of
the cytokines shown for 18 h and then
stained internally for Bcl-2 expression after
surface staining for CD8 and CD44. MFI
values relative to cells cultured without cy-
tokines are shown. (Right) Bcl-2 expression
in fresh CD44hi CD8  cells from normal B6
versus B6.IL-2R –/– mice. MFI values rela-
tive to staining of B6 cells are shown.289 Zhang et al.
CD44hi CD4  cells, and 1.4-fold for CD44int/lo CD4 
cells. Thus, resistance of old T cells to apoptosis was most
prominent in CD44hi CD8  cells and correlated with the
selective elevation of Bcl-2 in these cells. For the other T
cell subsets, the significant but less prominent decrease in
apoptosis of old T cells may have reflected minor upregula-
tion of Bcl-2, Bcl–XL, and/or other Bcl-2 family members
(which were not studied).
Bcl-2 Upregulation and T Cell Turnover. If the reduced
turnover of CD44hi CD8  cells in old mice reflected ele-
vated Bcl-2 expression, T cell turnover would be expected
to be reduced in Bcl-2 transgenic mice. Consistent with
this prediction it was found that, after transfer of young
Bcl-2 transgenic T cells to young normal hosts, the turn-
over (BrdU incorporation) of CD44hi CD8  cells was con-
siderably lower for donor Bcl-2 transgenic cells than for
normal host cells (Fig. 2 D). Because of their propensity to
develop lymphadenopathy, old Bcl-2 transgenic mice were
not studied.
Cytokine Levels. The capacity of IL-15 to upregulate
Bcl-2 expression on CD44hi CD8  cells raised the possibil-
ity that the overexpression of Bcl-2 in aged CD44hi CD8 
cells reflected increased levels of IL-15 in the aged mi-
croenvironment. Because IL-15 is difficult to detect at the
protein level, we measured IL-15 at the level of mRNA.
Since a spectrum of different cell types, including stromal
cells, synthesize IL-15 (25, 28), IL-15 mRNA was mea-
sured in whole spleen rather than in cell suspensions. As
shown in Table I, relative to G3PDH as a “housekeeping”
control, IL-15 mRNA levels in spleens of young and old
mice were quite similar.
Levels of IFN-I (IFN- ) mRNA were used as a control
in the above experiment. Interestingly, IFN-I mRNA lev-
els were appreciably higher (by 2.6-fold) in old versus
young spleens. To confirm this finding at the protein level,
we measured levels of IFN-I in the serum of old versus
young mice before and after injection of Poly I:C, a pow-
erful activator of IFN-I synthesis by macrophages and other
APC (38). As shown in Fig. 5 A, IFN-I levels before and
after Poly I:C were  2–3-fold higher in old mice than
young mice. Old mice also showed elevated baseline levels
of IFN-  and IL-12 but decreased levels of TNF- ; for IL-
12 and TNF-  (but not IFN- ), levels of these cytokines
increased after Poly I:C injection, both for young and old
mice. For IFN-I and TNF- , the fold-increase in cytokine
levels in old mice relative to young mice is shown in Fig. 5
B. As in serum, IFN-I synthesis by macrophages in re-
sponse to Poly I:C in vitro was higher for old than young
cells (Fig. 5 C).
The increased level of IFN-I in old mice is of interest
because, in young mice, IFN-I injection augments the
background rate of proliferation of CD44hi CD8  cells (but
not CD44hi CD4  cells) (38), apparently by inducing pro-
duction of IL-15 (23). As discussed earlier, at least in young
Figure 4. Spontaneous apoptosis of old versus young
T cells after culture in vitro in medium alone. Nylon-
wool-purified LN T cells from old versus young mice
were cultured in standard tissue culture medium (Ma-
terials and Methods). After 1 or 2 d, the cells were sur-
face stained for CD4, CD8, and CD44 followed by fix-
ation and internal staining by TUNEL for apoptosis.
The data show TUNEL staining on gated CD8  and
CD4  subsets of cells. Numbers refer to mean data ( 
SD) for triplicate cultures. Two other experiments gave
comparable results.
Table I. Whole Spleen RT-PCR: IL-15 and IFN-  versus 
G3PDH (  SD)
IFN-  IL-15
G3PDH G3PDH
Young B6 1.43 (0.22) 1.02 (0.11)
Old B6 3.71 (0.62) 1.25 (0.24)
Cytokines in young versus old mice. Expression of IL-15 and IFN- 
mRNA in spleens of young versus old mice detected by RT-PCR
(Materials and Methods). The data show mean values (three mice per
group   SD) of ratios of IL-15 and IFN-  mRNA relative to G3PDH
mRNA.290 Aging and T Cell Turnover
mice in vivo proliferation of CD44hi CD8  cells is largely
controlled by IL-15. Hence the increased levels of IFN-I in
old mice would be expected to augment IL-15 production
and thereby enhance CD44hi CD8  cell proliferation. Yet,
this was not the case, old mice showed near-normal levels
of IL-15 and a decrease rather than an increase in in vivo
proliferation of CD44hi CD8  cells. Therefore, we consid-
ered an alternative explanation for the data.
In addition to stimulating IL-15 production, IFN-I is
known to exert an antiproliferative effect on T cells (39–
41). Consistent with this observation we have found that,
in young mice, bystander proliferation of CD44hi CD8 
cells induced by injection of Poly I:C falls to low levels
when the dose of Poly I:C is raised above a certain level
(data not shown). It is conceivable therefore that the re-
duced turnover of CD44hi CD8  cells in old mice is due in
part to a direct antiproliferative effect on T cells mediated
by the increased levels of IFN-I. If so, it would follow that
old mice would show decreased responsiveness to exoge-
nous IL-15 and IL-15-inducing agents such as Poly I:C
(which induces IL-15 synthesis via production of IFN-I).
In line with this prediction, “bystander” proliferation of
CD44hi (IL-2R hi) CD8  cells elicited by injection of IL-
15 (Fig. 6 A) and Poly I:C (Fig. 6 B) was substantially
lower in old than young mice. Significantly, for Poly I:C,
this reduced responsiveness in old mice could be largely re-
versed by injection of anti–IFN-I antibody (Fig. 6 B).
Tests on purified CD44hi CD8  cells showed that old
and young T cells gave comparable proliferative responses
to IL-15 in vitro (Fig. 6 C). Under these conditions, it
would follow from the above in vivo data that adding even
low concentrations of IFN-I would decrease the in vitro
response to IL-15. This was indeed the case. Thus, the re-
sponse of old CD44hi CD8  cells to IL-15 in vitro was re-
duced by IFN-I concentrations as low as 40 U/ml (Fig. 6
D, see arrow), comparable to the levels found in the serum
of old mice; very similar data applied to young T cells (data
not shown). These in vitro data thus support the notion
that the limited in vivo response of aged CD44hi CD8 
cells to IL-15 reflects inhibition mediated by increased lev-
els of IFN-I.
Discussion
The main finding in this paper is that aging is associated
with a selective decrease in the turnover of memory-pheno-
type CD44hi CD8  cells. Based on adoptive transfer experi-
ments, the decreased turnover of CD44hi CD8  cells is con-
trolled by the milieu of the aged host environment. Two
distinct mechanisms, i.e., (i) overexpression of Bcl-2 and (ii)
inhibition by IFN-I, could account for this observation.
Bcl-2 Overexpression. For young mice, the data confirm
the recent report (37) that Bcl-2 expression is higher in
memory-phenotype CD8  cells than in other T cell sub-
sets. In extending this finding, we observed that Bcl-2 ex-
pression in CD44hi CD8  cells was even higher in old mice
but was not elevated in CD44hi CD4  cells. We also found
that, like Bcl-2, Bcl–XL expression was elevated in CD44hi
cells, both in young and old mice. Unlike Bcl-2, however,
Bcl–XL expression was upregulated in both CD44hi CD8 
and CD44hi CD4  cells and, for CD44hi CD8  cells, was
only slightly increased with aging. In agreement with the
known anti-apoptotic function of Bcl-2 (35), selective
overexpression of Bcl-2 in old CD44hi CD8  cells was as-
sociated with a prominent decrease in spontaneous apopto-
sis of these cells in vitro.
Why Bcl-2 expression is selectively upregulated in
CD44hi CD8  cells and is enhanced by aging is unclear.
Based on the effects of adding cytokines to purified T cells
in vitro, Bcl-2 upregulation may reflect contact with cyto-
kines, especially IL-15. Consistent with this finding, Bcl-2
expression was markedly reduced in IL-2R –/– CD44hi
Figure 5.  (A) Levels of cytokines in serum. To pre-
pare serum, blood was drawn from groups of old and
young mice before and after injection of Poly I:C (100
 g intraperitoneally); the mice were killed at each time
point shown. Serum concentrations of IFN-   (IFN-I),
IFN- , TNF- , and IL-12 were measured by ELISA;
note that the antibody used to detect IFN-I did not dis-
tinguish between IFN-  and IFN- . For IFN-   and
IL-12, serum from individual mice was tested, and the
data show mean values (  SD) for 4–6 mice for each
time point; where not shown, SDs were too small to
display. For IFN-  and TNF- , cytokine levels were
measured on serum pooled from 4–6 mice. (B) For
IFN-   and TNF- , the data in A are shown as fold-
increases for old mice relative to young mice. (C) To
measure cytokine production by macrophages, thiogly-
collate-induced macrophages from old and young mice
were cultured in vitro at 106 cells per milliliter, either
alone or in the presence of graded concentrations of
Poly I:C. Supernatants were taken from the cultures on
day 3 and concentrations of IFN-   were measured by
ELISA. The data show means (  SD) of cultures from
individual mice (four mice per group).291 Zhang et al.
CD8  cells, i.e., in T cells that lack a key receptor for IL-
15 (and IL-2). Hence continuous contact with IL-15 in
vivo may explain why Bcl-2 expression is much higher in
CD44hi CD8  cells (which are IL-2R hi and therefore IL-
15 responsive) than in CD44hi CD4  cells (IL-2R int).
However, it is more difficult to account for the further ele-
vation in Bcl-2 expression found in old CD44hi CD8 
cells. Here, the simplest idea is that IL-15 levels are in-
creased in old age. However, at least at the level of mRNA
in whole spleen, this was not the case, IL-15 levels being
only fractionally higher in old spleen than young spleen.
Nevertheless, the possibility that local concentrations of IL-
15 in the T cell areas, e.g., on dendritic cells (42), are
higher in old mice cannot be discounted. An alternative
possibility is that enhanced Bcl-2 expression in old CD44hi
CD8  cells reflects enhanced contact with other cytokines,
e.g., IL-4 or IL-7. Thus, like IL-15, these two cytokines
enhanced Bcl-2 expression in young T cells in vitro. As
yet, however, we have not measured levels of IL-4 and IL-7
in old versus young mice.
Whatever the mechanisms controlling Bcl-2 expression,
it is notable that overexpression of Bcl-2 in old CD44hi
CD8  cells correlated with a selective decrease in the back-
ground turnover of these cells in vivo. Hence, in view of
the evidence that Bcl-2 overexpression impairs entry into
cell cycle (30, 35, 36), the enhanced expression of Bcl-2 in
old CD44hi CD8  cells could be at least partly responsible
for the slow turnover of these cells in vivo. Support for this
idea is provided by the finding that, in young mice, the
turnover of CD44hi CD8  cells was much slower for Bcl-2
transgenic T cells than for normal T cells. For CD44hi
CD4  cells, aging was associated with little change in ei-
ther Bcl-2 or Bcl–XL expression and only a mild decrease
in T cell turnover (see below). Interestingly, others have
reported that, relative to young mice, CD44hi CD4  cells
from older lupus-prone BXSB mice show reduced T cell
turnover and apoptosis and increased Bcl–XL (but not Bcl-2)
expression (43). Hence, as for Bcl-2 in CD8  cells, en-
hanced Bcl–XL in CD4  cells may have an antiproliferative
effect on T cell turnover. It should be mentioned that slow
turnover of lymphoid cells in old mice has also been re-
ported for B cells (44). Whether this finding is related to
Bcl-2/Bcl–XL expression or increased IFN-I levels (see be-
low) has yet to be studied.
Inhibition by IFN-I. Of the limited number of cyto-
kines studied, levels of three cytokines, IFN-I, IFN- , and
IL-12 were about threefold higher in the serum of old mice
than in young mice. Elevation of IFN-I (which was also
found at the mRNA level) is of particular interest because
this cytokine can have two diametrically opposite effects on
CD44hi CD8  cells, i.e., (i) increased proliferation induced
by stimulation of IL-15 synthesis (23) and (ii) inhibition of
Figure 6. Capacity of IFN-I to inhibit responses of
CD44hi CD8  cells to IL-15. (A) Response of young
versus old mice to IL-15. Various doses of mouse rIL-15
were injected intravenously into young and old B6
mice. The mice were immediately injected with BrdU
and then given BrdU in the drinking water. On day 2
after IL-15 injection, LN cells pooled from two mice
per group were stained internally for BrdU incorpora-
tion after surface staining for CD4, CD8, and CD44.
The data show the percentage of BrdU  cells for gated
CD44hi and CD44lo CD8  cells. (B) Response of
young and old mice to Poly I:C (PI:C). (Left) young
versus old mice were injected with PI:C (100  g/
mouse intraperitoneally) and then given BrdU as in A,
followed by staining on day 3 for BrdU and surface
markers. Gating on CD44hi CD8  cells, the data show
the percentage BrdU  cells for LN pooled from two
mice. (Right) Old mice were injected with saline
(PBS), PI:C, or PI:C plus anti–IFN-  antiserum
(32,000 U/mouse given in two injections at 36 h and
48 h after PI:C) and given BrdU from day 0–3 fol-
lowed by staining for BrdU and surface markers. Gat-
ing on IL-2R hi CD8  cells, the data show mean per-
centage of BrdU  cells (  SD) for LN cells from three
mice; where not shown SDs were too small to display.
Gating on CD44hi CD8  cells ( 90% IL-2R hi) gave
similar results (data not shown). (C) Response of
young versus old CD44hi CD8  cells to IL-15 in vitro.
FACS®-purified CD44hi CD8  cells were cultured
with the indicated concentrations of rIL-15 for 2 d; 3[H]TdR was added during the last 8 h of culture.
The data show mean levels of 3[H]TdR incorporation for triplicate cultures (  SD). (D) Response of old
CD44hi CD8  cells to IL-15 in the presence of IFN-I. Purified CD44hi CD8  cells from old mice were
cultured with IL-15 (20 ng/ml) plus various concentrations of IFN-  (doubling dilutions down to 20 U/ml).
3[H]TdR was added on day 2. The data show mean levels of 3[H]TdR incorporation for triplicate cul-
tures on day 2. The arrow marks the response with IFN-  at 40 U/ml. For each experiment shown in
the figure, the data are representative of two to three separate experiments.292 Aging and T Cell Turnover
proliferation as the result of a direct inhibitory influence on
T cells (39–41). Since IL-15 levels were not noticeably en-
hanced in old mice, we considered the possibility that the
reduced turnover of old CD44hi CD8  cells in vivo re-
flected a direct antiproliferative response mediated by the
increased concentration of IFN-I found in old mice. In ac-
cordance with this idea, in vivo proliferation of CD44hi
CD8  cells after injection of IL-15 and IL-15-inducing
agents (Poly I:C) was clearly lower in old mice than in
young mice. Significantly, for Poly I:C, the reduction in T
cell turnover was reversed by injection of anti–IFN-I anti-
body. Likewise, preliminary work has shown that (a) anti–
IFN-I antibody injection partly reverses the slow tempo of
CD44hi CD8  cell turnover in old mice and (b) the slow
turnover of these cells is much less apparent in old IFN-IR–/–
mice (unpublished data).
If the reduced response of old T cells to IL-15 in vivo
reflected inhibition by IFN-I, it would follow that old
CD44hi CD8  cells would respond well to IL-15 in vitro
in the absence of IFN-I but would be highly sensitive to
inhibition by addition of exogenous IFN-I. This was in-
deed the case. In fact, concentrations of IFN-I as low as 40
U/ml caused an appreciable reduction in the in vitro re-
sponse to IL-15; this concentration of IFN-I was close to
the level found in the serum of old mice. It is important to
note that in vitro responses to IL-15 were highly sensitive
to even moderate (twofold) alterations in the concentration
of IFN-I in vitro. This finding supports the view that the
approximately threefold increase in IFN-I levels found in
old mice is sufficient to exert an antiproliferative effect on
T cells.
Since the antiproliferative effect of IFN-I is not restricted
to CD44hi CD8  cells, enhanced exposure to IFN-I in old
mice would be expected to retard the turnover of CD44hi
CD4  cells as well as CD44hi CD8  cells. On this point it
should be noted that the decrease in T cell turnover in old
mice did affect CD44hi CD4  cells, though to a lesser ex-
tent than CD44hi CD8  cells. Nevertheless, the fact that
slow turnover of old T cells was more prominent in
CD44hi CD8  cells than CD44hi CD4  cells implies that
inhibition by IFN-I is not the sole explanation. For this
reason, we favor the idea that the selective decrease in the
turnover of CD44hi CD8  cells in old mice reflects the
combined inhibitory effects of two different mechanisms
working together, i.e., enhanced IFN-I levels plus Bcl-2
overexpression.
The significance of reduced T cell turnover in aging is a
matter for speculation. Since thymic function is poor after
middle age, maintaining T cell numbers in old age presum-
ably hinges on continuous contact with factors that pro-
mote long-term T cell survival. For CD44hi CD8  cells, at
least in young mice exposure to IL-15 is crucial for sur-
vival. How IL-15 protects CD44hi CD8  cells is unclear
but, based on the present data, upregulation of Bcl-2 and/
or other antiapoptotic molecules is a likely possibility. Plac-
ing the survival of T cells under the control of life-sustain-
ing cytokines, however, has the potential danger that even
transient increases in these growth factors could cause T
cell numbers to rise to excessive levels. Hence to maintain
normal homeostasis, one can envisage a delicate equilib-
rium where factors controlling T cell survival/proliferation
are balanced by other factors that either promote cell death
or inhibit proliferation. Hence, the increase in Bcl-2 ex-
pression and IFN-I levels in aging could be a manifestation
of a general need to regulate T cell homeostasis in senes-
cence. It is worth noting, however, that Bcl-2 and IFN-I
do not act solely as negative regulators. Thus, countering
their inhibitory effect on proliferation, Bcl-2 (30) and IFN-I
(45) may augment cell survival via their antiapoptotic prop-
erties (and via IL-15 production by IFN-I). Hence, the
control of T cell homeostasis in aging is undoubtedly
highly complex and presumably reflects the interplay of
many different factors.
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